The purpose of the Cellular and Animal Modeling Core is to provide both tissues and tissue processing and afacility for the development of novel epithelial cell lines from the intestinal tissues of transgenic mice. Thefocus of the core's efforts will be on intestinal diseases with the intent to improve human health throughadvances in prevention, diagnosis, or prevention of digestive diseases. The core has two components: theNovel Cell Line Development Subcore and the Tissue Morphology Subcore.The Novel Cell Line Development Subcore provides a unique service in developing conditionallyimmortalized epithelial cell lines from the different segments of the gastrointestinal tract of transgenic micewith gene deletions known to be associated with known gastrointestinal pathologies. One of the majorimpediments in gastrointestinal research has been the lack of normal epithelial cell lines derived fromintestinal mucosa. This subcore addresses this lack by utilizing a novel transgenic mouse, the'Immortomouse,' which carries a temperature-sensitive mutant of the SV40 large T gene, which is animmortalizing gene. The temperature-sensitive form of this gene is only active at the permissive temperature(33 C) and is inactivated by incubation at 39 C. This means that primary cells isolated from the intestinalepithelium can be immortalized by incubation at the permissive temperature but then reverted to a normalphenotype by increasing the incubation temperature to 39 C. The introduction of this immortalizing gene intothe transgenic mouse of interest is achieved by mating a transgenic mouse with the Immortomouse. Aftertwo rounds of mating, mice homozygous for the transgene or knockout phenotype and carrying theimmortalizing gene are obtained. Tissues from these animals can then be cultured using techniquespublished by the core director. To date these methods have been successfully used to develop 50 epithelialcell lines from different gastrointestinal tissues, including stomach, small intestine, colon, pancreas, and liverfrom 10 different transgenic mice. The Tissue Morphology Subcore provides services for the acquisition ofhuman intestinal tissue and for the histologic processing of both human and animal intestinal tissue. Inaddition, Dr. Washington, the core Director, provides the necessary expertise for interpretation of thehistologic findings obtained in these studies. The availability of a central service such as this with allspecimens being processed by one highly skilled histology technician enhances the findings from the othercores, as it provides a level of consistency in the interpretation of histologic changes found in the animalmodels being used by members of the VDDRC. In addition, this subcore provides a supply of high quality,rapidly processed human specimens as required by the VDDRC investigators.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK058404-06
Application #
7283911
Study Section
Special Emphasis Panel (ZDK1-GRB-4 (J1))
Project Start
2007-06-01
Project End
2012-05-31
Budget Start
2007-06-01
Budget End
2008-05-31
Support Year
6
Fiscal Year
2007
Total Cost
$207,126
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Lindsey, Amelia R I; Rice, Danny W; Bordenstein, Sarah R et al. (2018) Evolutionary Genetics of Cytoplasmic Incompatibility Genes cifA and cifB in Prophage WO of Wolbachia. Genome Biol Evol 10:434-451
Lopez, Christopher A; Skaar, Eric P (2018) The Impact of Dietary Transition Metals on Host-Bacterial Interactions. Cell Host Microbe 23:737-748
Roberts, Jordan; Gonzalez, Raul S; Revetta, Frank et al. (2018) Mesenteric tumour deposits arising from small-intestine neuroendocrine tumours are frequently associated with fibrosis and IgG4-expressing plasma cells. Histopathology 73:795-800
Schulte, Michael L; Fu, Allie; Zhao, Ping et al. (2018) Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models. Nat Med 24:194-202
Singh, Kshipra; Coburn, Lori A; Asim, Mohammad et al. (2018) Ornithine Decarboxylase in Macrophages Exacerbates Colitis and Promotes Colitis-Associated Colon Carcinogenesis by Impairing M1 Immune Responses. Cancer Res 78:4303-4315
Cooke, Allison L; Morris, Jamie; Melchior, John T et al. (2018) A thumbwheel mechanism for APOA1 activation of LCAT activity in HDL. J Lipid Res 59:1244-1255
Mera, Robertino M; Bravo, Luis E; Camargo, M Constanza et al. (2018) Dynamics of Helicobacter pylori infection as a determinant of progression of gastric precancerous lesions: 16-year follow-up of an eradication trial. Gut 67:1239-1246
Skoog, Emma C; Morikis, Vasilios A; Martin, Miriam E et al. (2018) CagY-Dependent Regulation of Type IV Secretion in Helicobacter pylori Is Associated with Alterations in Integrin Binding. MBio 9:
Gibson, William E; Gonzalez, Raul S; Cates, Justin M M et al. (2018) Hepatic micrometastases are associated with poor prognosis in patients with liver metastases from neuroendocrine tumors of the digestive tract. Hum Pathol 79:109-115
Galligan, James J; Wepy, James A; Streeter, Matthew D et al. (2018) Methylglyoxal-derived posttranslational arginine modifications are abundant histone marks. Proc Natl Acad Sci U S A 115:9228-9233

Showing the most recent 10 out of 1365 publications